Using MRD to Guide Therapy in AML

September 16, 2017
Harry Erba, MD, PhD

Harry Erba, MD, PhD, professor of medicine, director, University of Alabama (UAB) Hematologic Malignancy Program, UAB School of Medicine, discusses using MRD to guide therapy in acute myeloid leukemia (AML).